Design Considerations for Using the Tree-based Scan Statistic in Surveillance of Maternal Outcomes Following Medication Use during Gestation

This poster assesses TreeScan’s signal identification performance to identify signals for maternal and obstetric adverse outcomes from 20 weeks of gestation to 30 days after delivery among patients with livebirths exposed to oral macrolide compared to beta-lactam antibiotics. It was presented at the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.